3,514 research outputs found

    Drug development: Lessons from nature.

    Get PDF
    Natural products have been acknowledged for numerous years as a vital source of active ingredients in therapeutic agents. In particular, the use of active ingredients derived from plants for use in microbial natural products have long been used before the dawn of modern medicine. From ancient times, the efficacy of natural products has been associated with the chemistry, biochemistry and synthetic activities of natural products. Thus, with scientific advancement in modern molecular and cellular biology, analytical chemistry and pharmacology, the unique properties of these natural products are being harnessed in order to exploit the chemical and structural diversity and biodiversity of these types of products in relation to their therapeutic effect. Often, new molecules of interest in drug design units focus on the rearrangement of chemical entities or structural isomers of naturally occurring products in order to generate new molecules; these may be formulated into clinically useful therapies

    Kentucky Law Survey: Torts

    Get PDF

    Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial

    Get PDF
    Carboplatin/taxane combination is first-line therapy for ovarian cancer. However, patients can encounter treatment delays, impaired quality of life, even death because of chemotherapy-induced gastrointestinal (GI) toxicity. A candidate gene study was conducted to assess potential association of genetic variants with GI toxicity in 808 patients who received carboplatin/taxane in the Scottish Randomized Trial in Ovarian Cancer 1 (SCOTROC1). Patients were randomized into discovery and validation cohorts consisting of 404 patients each. Clinical covariates and genetic variants associated with grade III/IV GI toxicity in discovery cohort were evaluated in replication cohort. Chemotherapy-induced GI toxicity was significantly associated with seven single-nucleotide polymorphisms in the ATP7B, GSR, VEGFA and SCN10A genes. Patients with risk genotypes were at 1.53 to 18.01 higher odds to develop carboplatin/taxane-induced GI toxicity (P<0.01). Variants in the VEGF gene were marginally associated with survival time. Our data provide potential targets for modulation/inhibition of GI toxicity in ovarian cancer patients

    On the importance of testing gravity at distances less than 1cm

    Get PDF
    If the mechanism responsible for the smallness of the vacuum energy is consistent with local quantum field theory, general arguments suggest the existence of at least one unobserved scalar particle with Compton wavelength bounded from below by one tenth of a millimeter. We show that this bound is saturated if vacuum energy is a substantial component of the energy density of the universe. Therefore, the success of cosmological models with a significant vacuum energy component suggests the existence of new macroscopic forces with range in the sub-millimeter region. There are virtually no experimental constraints on the existence of quanta with this range of interaction.Comment: 9 pages TeX, 2 eps figures, uses mtexsis.tex and epsf.tex. Entry in 1996 Gravity Research Foundation essay competition. To be published in the Journal of General Relativity and Gravitatio

    A GIT interpretration of the Harder-Narasimhan filtration

    Get PDF
    An unstable torsion free sheaf on a smooth projective variety gives a GIT unstable point in certain Quot scheme. To a GIT unstable point, Kempf associates a "maximally destabilizing" 1-parameter subgroup, and this induces a filtration of the torsion free sheaf. We show that this filtration coincides with the Harder-Narasimhan filtration.Comment: 19 pages; Comments of the referees and references added. The construction for holomorphic pairs (Sections 6 and 7 from previous version) will appear in a further publication. To appear in Rev. Mat Complutens
    corecore